Literature DB >> 19300227

Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.

Steven C Katz1, Jinru Shia, Kui Hin Liau, Mithat Gonen, Leyo Ruo, William R Jarnagin, Yuman Fong, Michael I D'Angelica, Leslie H Blumgart, Ronald P Dematteo.   

Abstract

OBJECTIVE: To determine if the degree of blood loss during resection of hepatocellular carcinoma (HCC) is predictive of recurrence and long-term survival.
BACKGROUND: Several studies have addressed the impact of blood transfusion on survival and recurrence after liver resection for HCC. However, the independent effect of intraoperative estimated blood loss (EBL) on oncologic outcome is unclear.
METHODS: From our prospective database, we identified 192 patients who had a partial hepatectomy for HCC from 1985 to 2002. Clinicopathologic predictors of EBL were identified using logistic regression. Overall survival (OS), disease-specific survival (DSS), and recurrence free survival (RFS) were assessed using the Kaplan-Meier and Cox regression methods.
RESULTS: The median patient age was 64 (range, 19-86) and 66% were men. All patients had histologically proven HCC. The median follow-up time was 34 months (range, 1-297). Factors associated with increased EBL on multivariate analysis were male gender, vascular invasion, extent of hepatectomy, and operative time (P < 0.01). EBL and vascular invasion were independent predictors of OS and DSS. Only EBL was significantly associated with RFS on multivariate analysis (P = 0.02). Additionally, we found a significant inverse correlation between increasing levels of EBL and length of DSS (P = 0.01).
CONCLUSIONS: The magnitude of EBL during HCC resection is related to biologic characteristics of the tumor as well as the extent of surgery. Increased intraoperative blood loss during HCC resection is an independent prognostic factor for tumor recurrence and death.

Entities:  

Mesh:

Year:  2009        PMID: 19300227     DOI: 10.1097/SLA.0b013e31819ed22f

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  134 in total

1.  Equivalent outcomes after anatomical and non-anatomical resection of small hepatocellular carcinoma in patients with preserved liver function.

Authors:  Yoshito Tomimaru; Hidetoshi Eguchi; Shigeru Marubashi; Hiroshi Wada; Shogo Kobayashi; Masahiro Tanemura; Koji Umeshita; Yuichiro Doki; Masaki Mori; Hiroaki Nagano
Journal:  Dig Dis Sci       Date:  2012-03-11       Impact factor: 3.199

Review 2.  Management before hepatectomy for hepatocellular carcinoma with cirrhosis.

Authors:  Hisashi Nakayama; Tadatoshi Takayama
Journal:  World J Hepatol       Date:  2015-09-18

Review 3.  Role of surgical resection for hepatocellular carcinoma based on Japanese clinical guidelines for hepatocellular carcinoma.

Authors:  Hisashi Nakayama; Tadatoshi Takayama
Journal:  World J Hepatol       Date:  2015-02-27

4.  Hemorrhage control for laparoscopic hepatectomy: technical details and predictive factors for intraoperative blood loss.

Authors:  Yoshikuni Kawaguchi; Takeo Nomi; David Fuks; Frederic Mal; Norihiro Kokudo; Brice Gayet
Journal:  Surg Endosc       Date:  2015-08-27       Impact factor: 4.584

5.  No impact of perioperative blood transfusion on recurrence of hepatocellular carcinoma after hepatectomy.

Authors:  Shintaro Kuroda; Hirotaka Tashiro; Tsuyoshi Kobayashi; Akihiko Oshita; Hironobu Amano; Hideki Ohdan
Journal:  World J Surg       Date:  2012-03       Impact factor: 3.352

6.  The Impact of Intraoperative Blood Loss on the Survival of Patients With Stage II/III Pancreatic Cancer.

Authors:  Hiroshi Tamagawa; Toru Aoyama; Naoto Yamamoto; Mariko Kamiya; Masaaki Murakawa; Yosuke Atsumi; Masakatsu Numata; Keisuke Kazama; Kentaro Hara; Norio Yukawa; Yasushi Rino; Munetaka Masuda; Soichiro Morinaga
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

7.  Impact of intraoperative blood loss on long-term survival after lung cancer resection.

Authors:  Haruhiko Nakamura; Hisashi Saji; Noriaki Kurimoto; Takuo Shinmyo; Rie Tagaya
Journal:  Ann Thorac Cardiovasc Surg       Date:  2014-02-28       Impact factor: 1.520

Review 8.  Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols.

Authors:  Danijel Galun; Dragan Basaric; Marinko Zuvela; Predrag Bulajic; Aleksandar Bogdanovic; Nemanja Bidzic; Miroslav Milicevic
Journal:  World J Hepatol       Date:  2015-09-18

9.  A multicentre, randomized clinical trial comparing the Veriset™ haemostatic patch with fibrin sealant for the management of bleeding during hepatic surgery.

Authors:  Robert Öllinger; Andre L Mihaljevic; Christoph Schuhmacher; Hüseyin Bektas; Florian Vondran; Moritz Kleine; Mauricio Sainz-Barriga; Sascha Weiss; Phillip Knebel; Johann Pratschke; Roberto I Troisi
Journal:  HPB (Oxford)       Date:  2012-12-27       Impact factor: 3.647

10.  A comprehensive assessment of transfusion in elective pancreatectomy: risk factors and complications.

Authors:  Raphael C Sun; Anna M Button; Brian J Smith; Richard F Leblond; James R Howe; James J Mezhir
Journal:  J Gastrointest Surg       Date:  2013-02-20       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.